Eliminating racial disparities in severe maternal morbidity by addressing hypertension in the year after delivery
通过解决产后一年的高血压问题消除严重孕产妇发病率的种族差异
基本信息
- 批准号:10528532
- 负责人:
- 金额:$ 63.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-30 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdherenceAdverse eventAffectBiometryBlack raceBlood PressureBlood Pressure MonitorsCOVID-19 pandemicCardiac healthCardiovascular DiseasesCaringCessation of lifeChronicClinicalClinical TrialsCommunitiesCoupledDataDiscipline of obstetricsDiseaseEducationEnrollmentEnsureEpidemiologyEventFamily PracticeGuidelinesHealthHealth ProfessionalHeart DiseasesHeart failureHome Blood Pressure MonitoringHome visitationHospitalsHypertensionIncidenceInterventionKnowledgeLife StyleMaternal MortalityMaternal and Child HealthMeasurementMissionMonitorMothersNational Institute on Minority Health and Health DisparitiesOutcomePatientsPlant RootsPopulationPostpartum PeriodPre-EclampsiaPregnancyPsychiatryRecoveryResearchRiskServicesSingle-Blind StudySiteStrokeSystemTestingTimeWeightWomanWomen&aposs Healthblack womenblood pressure controlclinical applicationclinical carecommunity engagementcommunity interventioncommunity partnershipcommunity-level factorevidence baseexperiencefeasibility trialhealth care disparityhealth care servicehealth equityhealth inequalitieshigh riskimprovedinnovationmaternal morbiditymortalitymultidisciplinarynovelpostpartum complicationspregnancy disorderpregnancy hypertensionpressurepreventprogramsracial differenceracial disparityracial minority populationrandomized trialrecruitservice deliverysevere maternal morbiditysocial mediasocioeconomicstreatment as usualtrendtrial comparingtwo-arm trialvirtual interventionwireless
项目摘要
ABSTRACT
The increasing rate of severe maternal morbidity and mortality events in the U.S.
disproportionately burdens Black women. Black women are 3 to 4 times more likely than white
women to suffer or die from complications during or after pregnancy. Hypertensive disorders of
pregnancy (HDP) (e.g., preeclampsia, gestational hypertension) are major contributors to severe
maternal morbidity and mortality, as well as long-term cardiovascular disease (CVD). Black
women are more likely than white women to have severe forms of HDP and severe post-partum
complications such as chronic hypertension, stroke and CVD. We have compelling preliminary
data that documents racial disparities in the post-partum blood pressure recovery profile among
women with HDP at 6 weeks and 12 months after delivery. Despite an overall downward trend in
post-partum blood pressures among women with HDP, Black women have higher blood
pressures and are more likely to have stage 2 hypertension (≥140/90 mmHg) at 6 weeks
postpartum compared to white women (32.4% versus.18.2%, p <0.001); trends that persist to one
year after delivery. We propose to decrease the racial disparity in blood pressure control at one
year postpartum among women with HDP by leveraging our hospital-initiated 6-week home blood
pressure monitoring program (HBPM) for women with HDP and our novel community-partnered
multi-level intervention with Healthy Start Inc. We aim to: 1) test an enhanced care intervention
strategy (6 weeks of HBPM, postpartum doula education and support, 12 months of wireless
HBPM and weight monitoring) compared to usual care control (6 weeks of HBPM) to improve the
blood pressure profile among women with HDP; 2) determine if an enhanced care strategy will
eliminate racial disparities in BP profiles, and 3) determine the access to and delivery of equitable
clinical care that is essential for all women to successfully recover from HDP within one year
postpartum. We hypothesize that the enhanced care intervention rooted within a health equity
framework will improve the post-partum blood pressure recovery profile among women with HDP
and will close the blood pressure disparity between Black and White women in the year after
delivery. Our approach will be to conduct a parallel, two-arm trial that randomizes 454 women
with HDP (75% Black, 25% White) into usual care or an enhanced care intervention to improve
blood pressure control in the year after delivery. Improving blood pressure control is essential to
prevent progression to chronic hypertension, reduce racial disparities in hypertension, and
improve women’s health overall.
摘要
在美国,严重的孕产妇发病率和死亡率不断上升。
黑人妇女的负担过重。黑人女性比白色女性多3到4倍
妇女在怀孕期间或之后患上或死于并发症。高血压疾病
妊娠(HDP)(例如,先兆子痫,妊娠高血压)是严重的
产妇发病率和死亡率以及长期心血管疾病(CVD)。黑色
妇女比白色妇女更有可能患有严重形式的HDP和严重的产后
慢性高血压、中风和心血管疾病等并发症。我们有确凿的初步证据
记录产后血压恢复情况的种族差异的数据,
分娩后6周和12个月时患有HDP的女性。尽管总体呈下降趋势,
HDP妇女的产后血压,黑人妇女的血压更高,
在6周时,更有可能患有2期高血压(≥140/90 mmHg)
产后与白色妇女相比(32.4%对18.2%,p <0.001);趋势持续到1
交付后一年。我们建议减少血压控制的种族差异,
利用我们医院发起的6周家庭采血,
压力监测计划(HBPM)的妇女与HDP和我们的新的社区合作伙伴
多层次的干预与健康的开始公司。我们的目标是:1)测试增强护理干预
策略(6周HBPM,产后导乐教育和支持,12个月无线
HBPM和体重监测)与常规护理对照(6周HBPM)相比,
HDP女性的血压特征; 2)确定加强护理策略是否会
消除BP档案中的种族差异,3)确定获得和提供公平的
临床护理对于所有女性在一年内成功从HDP中恢复至关重要
产后我们假设,加强护理干预植根于健康公平
框架将改善HDP妇女的产后血压恢复状况
并将在一年后缩小黑人和白色女性之间的血压差距
交付.我们的方法是进行一项平行的两组试验,随机选择454名妇女
HDP患者(75%黑人,25%白色)接受常规护理或加强护理干预,以改善
产后一年内血压控制。改善血压控制至关重要,
预防进展为慢性高血压,减少高血压的种族差异,
全面改善妇女健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janet M Catov其他文献
Janet M Catov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janet M Catov', 18)}}的其他基金
Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife
先兆子痫和大脑:中年早期的小血管疾病和认知功能
- 批准号:
10552017 - 财政年份:2022
- 资助金额:
$ 63.29万 - 项目类别:
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH)
扩大幼儿期家庭检查,促进母婴心血管健康 (ENRICH)
- 批准号:
10427592 - 财政年份:2022
- 资助金额:
$ 63.29万 - 项目类别:
Eliminating racial disparities in severe maternal morbidity by addressing hypertension in the year after delivery
通过解决产后一年的高血压问题消除严重孕产妇发病率的种族差异
- 批准号:
10693282 - 财政年份:2022
- 资助金额:
$ 63.29万 - 项目类别:
Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH)
扩大幼儿期家庭检查,促进母婴心血管健康 (ENRICH)
- 批准号:
10622517 - 财政年份:2022
- 资助金额:
$ 63.29万 - 项目类别:
Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife
先兆子痫和大脑:中年早期的小血管疾病和认知功能
- 批准号:
10370575 - 财政年份:2022
- 资助金额:
$ 63.29万 - 项目类别:
Preconception contributors to severe maternal morbidity in black and white women
怀孕前导致黑人和白人妇女严重孕产妇发病的因素
- 批准号:
10200386 - 财政年份:2019
- 资助金额:
$ 63.29万 - 项目类别:
Shared Antecedents to Pre-term Birth and Cardiovascular Disease in Women
女性早产和心血管疾病的共同原因
- 批准号:
9903432 - 财政年份:2019
- 资助金额:
$ 63.29万 - 项目类别:
Preterm Delivery and Maternal Cardiovascular Disease Risk
早产和孕产妇心血管疾病风险
- 批准号:
8138480 - 财政年份:2010
- 资助金额:
$ 63.29万 - 项目类别:
Preterm Delivery and Maternal Cardiovascular Disease Risk
早产和孕产妇心血管疾病风险
- 批准号:
7947722 - 财政年份:2010
- 资助金额:
$ 63.29万 - 项目类别:
Preterm Delivery and Maternal Cardiovascular Disease Risk
早产和孕产妇心血管疾病风险
- 批准号:
8499402 - 财政年份:2010
- 资助金额:
$ 63.29万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 63.29万 - 项目类别:
Fellowship Programs